Results 141 to 150 of about 17,702 (177)

Fungemia caused by <i>Cyberlindnera fabianii</i>: Clinical and microbiological insights from two fatal cases. [PDF]

Med Mycol Case Rep
Sarzyński M, Łuczak M, Bekier A, Miaśkiewicz E, Pastuszak-Lewandoska D, Brauncajs M.   +5 more
europepmc   +1 more source

<i>In vitro</i> exposure to the agricultural triazole tebuconazole selects for fluconazole cross-resistance and echinocandin tolerance in <i>Candidozyma auris</i>. [PDF]

Front Cell Infect Microbiol
Peng L, Xu Y, Chen X, Li W, Guo L.
europepmc   +1 more source

<i>Candida glabrata</i> Isolated From Tubo-Ovarian Abscess Cultures in Two Immunocompetent Patients. [PDF]

Clin Case Rep
Hirsch M, DePaola R, Eisenberg J, Shay A, Moore TM, Katz A, Stein RA.   +6 more
europepmc   +1 more source

Combination antifungal therapy against resistant C. albicans: efficacy and immune response in mice. [PDF]

AMB Express
Taghizadeh-Maleki A, Hatami F, Seyedjavadi SS, Asghari-Paskiabi F, Jahanshiri Z.   +4 more
europepmc   +1 more source

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials. [PDF]

Open Forum Infect Dis
Ostrosky-Zeichner L, Aram JA, Redell M, Thompson GR, Cornely OA, McKinnell JA, Spec A, Pappas PG.   +7 more
europepmc   +1 more source

Clinical Outcomes of <i>Candida auris</i> Versus Other <i>Candida</i> Species Bloodstream Infections: An IPTW-Adjusted Cohort Study in South Korea. [PDF]

J Fungi (Basel)
Sung M, Jang S, Leem AY, Lee CH, Chung KS, Kim YS, Kim J, Lee SH.   +7 more
europepmc   +1 more source

Efficacies of Conventional Antifungals and Complementary and Alternative Medicine as Single or Combination Therapies Against <i>Candida</i> Biofilms in Recurrent Vaginal Candidiasis: An In Vitro Study. [PDF]

J Fungi (Basel)
Pan Y, Ye L, Chen L, Hermann L, Jin P, Cai Y, Cheng Y, Zhang W, Watson CJ, McGiffin D, Luo Q, Zhu X, Qu Y.   +12 more
europepmc   +1 more source

Synergistic activity of caspofungin and posaconazole against <i>Candida</i> (<i>Candidozyma</i>) <i>auris</i> biofilms based on phenotypic, transcriptomic, and <i>in vivo</i> insights. [PDF]

Microbiol Spectr
Kovács F, Harmath A, Balázsi D, Forgács L, Ragyák Á, Balla N, Tóth Z, Bozó A, Borman AM, Majoros L, Kovács R, Jakab Á.   +11 more
europepmc   +1 more source

Rezafungin exhibits anti-biofilm properties against fungal biofilms in vitro. [PDF]

J Antimicrob Chemother
Abduljalil H, Bartie K, Bal AM, Bal AM, Rautemaa-Richardson R, Williams C, Kean R, Ramage G.   +7 more
europepmc   +1 more source

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source